Biocon turns to captive solar power from AMPIN to lower energy costs and carbon emissions
Britannia drops while Thermax, Sonata, Pidilite and Dabur rally after Q4FY26 earnings and major block deals.
Biocon founder Kiran Mazumdar-Shaw names niece Claire Mazumdar as successor under a phased five-year transition plan.
Claire,37, is the daughter of Shaw’s brother. She has studied biological engineering at MIT, then went to Stanford for two…
In a post on social network platform X, formerly Twitter, Shaw detailed out that Claire will eventually step into the…
Over 270 companies, including L&T, M&M, Swiggy, and Paytm, will announce earnings and possible dividends this week. Stay updated on…
Sensex & Nifty tank 1.5% as Vedanta adjusts for demerger and HUL slips post-Q4. Bajaj Finance defies the trend—here is…
India’s ₹10,000 crore Biopharma SHAKTI scheme marks a definitive shift from low-cost generics to high-value biologics, aiming to integrate local…
India’s Testing, Inspection, and Certification (TIC) market is projected to hit $10.9 billion by 2034, driven by stringent regulations in…
A sharp sell-off gripped markets as pharma stocks plunged on US tariff fears and rising crude prices dragged key sectors,…
Biocon’s Siddharth Mittal steps down as MD & CEO; Shreehas Tambe, a 30-year company veteran with 61 patents, takes over…
Semaglutide prices in India are set to drop sharply as generics enter the market after patent expiry, improving affordability for…
Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!
With 55% of crude imports and $75 billion trade tied to West Asia, India can’t ignore Strait of Hormuz tensions.…
Motilal Oswal raises the price target for Tata Steel and maintains ‘Buy,’ forecasting a 15% upside—discover 5 reasons driving their…
Nuvama has flagged four pharma stocks as top ‘Buy’ picks, citing strong US launches, biosimilars traction and margin expansion with…
Stocks to watch today, February 13: Track the latest stock updates and key Q3 results before the budget—discover which stocks…
Nirmala Sitharaman’s Biopharma SHAKTI announcement in the Union Budget has worked as a booster for the biotechnology sector that was…